|
ECB--23180630
Papers associated with LOC115919910 (and LOC115921826)
???pagination.result.count???
???pagination.result.page??? 1
Sort Newest To Oldest | Sort Oldest To Newest |
IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms., de Melo Campos P, Machado-Neto JA, Eide CA, Savage SL, Scopim-Ribeiro R, da Silva Souza Duarte A, Favaro P, Lorand-Metze I, Costa FF, Tognon CE, Druker BJ, Olalla Saad ST, Traina F., Oncotarget. February 9, 2016; 7 (6): 6948-59. |
|
Stathmin 1 inhibition amplifies ruxolitinib-induced apoptosis in JAK2V617F cells., Machado-Neto JA, de Melo Campos P, Favaro P, Lazarini M, da Silva Santos Duarte A, Lorand-Metze I, Costa FF, Saad ST, Traina F., Oncotarget. October 6, 2015; 6 (30): 29573-84. |
???pagination.result.page??? 1